Summary
The persistence of TSH receptor antibodies in Graves' disease despite the remission of hyperthyroidism has been described. Our study was designed to evaluate whether this extends to functionally active stimulators of the thyroid, since the occurrence of thyroid-stimulating antibodies (TSAb) in a euthyroid patient could well have important implications on our understanding of the pathogenetic role of such autoantibodies. Forty-four patients with a previous history of Graves' hyperthyroidism were reexamined after having been in long-lasting remission for 3 to 35 years (mean 8 years). Of the patients 16 had been treated by radioiodine, 17 by surgery, and 11 exclusively by antithyroid drugs. The determination of TSAb was based on T3 release from thyroid tissue in vitro to document the final response to these immunoglobulins. TSH-binding inhibiting immunoglobulins (TBII) were evaluated by a radioreceptor assay.
TSAb were highly elevated in three of the 44 patients. These three patients showed a normal TSH response to i.v. TRH, suffered from endocrine ophthalmopathy, and had been treated by radioiodine for hyperthyroidism. TBII were found positive in seven patients including the three patients mentioned. The majority of patients positive for TSAb or TBII had been treated by radioiodine and none exclusively by antithyroid drugs.
In conclusion, not only TBII but also T3 release-stimulating antibodies may occur in a minority of patients with long-term remission of Graves' hyperthyroidism. However, an absence of hyperthyroidism in these patients despite the presence of such thyroid stimulators seems to be only possible in association with a lack of functional responsiveness of the target organ due to previous administration of destructive therapies. Moreover, a major role of TBII in the absence of TSAb representing stimulatory inactive autoantibodies to the maintenance of remission was not apparent.
Similar content being viewed by others
Abbreviations
- cAMP:
-
cyclic adenosine monophosphate
- T3:
-
triiodothyronine
- T4:
-
tetraiodothyronine
- TBII:
-
TSH-binding inhibiting immunoglobulins
- TRH:
-
TSH-releasing hormone
- TSAb:
-
thyroid-stimulating antibodies
- TSH:
-
thyroidstimulating hormone
References
Atkinson S, Kendall-Taylor P (1981) The stimulation of thyroid hormone secretion in vitro by thyroid-stimulating antibodies. J Clin Endocrinol Metab 53:1263–1266
Atkinson S, McGregor M, Kendall-Taylor P, Peterson MM, Smith BR (1982) Effect of radioiodine on stimulatory activity of Graves' immunoglobulins. Clin Endocrinol (Oxf) 13:537–543
Bech K, Madsen N (1980) Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves' disease. Clin Endocrinol (Oxf) 13:417–424
Bliddal H, Kirkegaard C, Siersbaek-Nielsen K, Friis T (1981) Prognostic value of thyrotropin binding inhibiting immunoglobulins (TBII) in long-term antithyroid treatment,131I therapy given in combination with carbimazole and in euthyroid ophthalmopathy. Acta Endocrinol (Copenh) 98:364–369
Bliddal H, Bech K, Kirkegaard C (1984) Thyroid stimulating immunoglobulins in patients in long-term remission after Graves' disease. Horm Metab Res 16:602–605
Doctor R, Bos G, Visser TJ, Henneman G (1980) Thyrotropin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator. Clin endocrinol (Oxf) 12:143–153
Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y, Mori T, Torizuka K (1978) Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 46:734–739
Hörmann R, Saller B, Müller R, Hobelsberger A, Moser E, Mann K (1985) Methodische Probleme and klinische Wertigkeit der Bestimmung von TSH-Rezeptor-Antikörper mit einem kommerziellen Kit. Lab Med 9:208–213
Hörmann R, Saller B, Müller R, Mann K (1985) Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease. Klin Wochenschr 63:1247–1252
Kjaerulff H, Bech K, Bliddal H (1984) Isolation of thyroid stimulating immunoglobulins by affinity chromatography using protein A sepharose. Acta Endocrinol (Copenh) 106:79–85
Madec AM, Laurent MC, Lorcy Y, LeGuerrieer AM, Rostagnat-Stefanutti A, Orgiazzi J, Allannic H (1984) Thyroid stimulating antibodies: an aid to the strategy of Graves' disease? Clin Endocrinol (Oxf) 21:247–255
Mann K, Schneider N, Hoermann R (1986) Thyrotropic activity of acidic isoelectric variants of human chorionic gonadotropin from trophoblastic tumors. Endocrinology 118:1558–1566
McGregor AM, Smith BR, Hall R (1980) Prediction of relapse in hyperthyroid Graves' disease. Lancet II:1101–1103
Schleusener H, Finke R, Kotulla P, Wenzel KW, Meinhold H, Roedler HD (1978) Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of the disease? J Endocrinol Invest 2:155–161
Shewring G, Smith BR (1982) An improved radioreceptor assay for TSH receptor antibodies. Clin endocrinol (Oxf) 17:409–417
Valente WA, Vitti P, Yavin Z, Yavin E, Rotella CM, Grollmann EF, Toccafondi RS, Kohn LD (1982) Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves' disease. Proc Natl Acad Sci USA 79:6680–6686
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hörmann, R., Hobelsberger, A., Saller, B. et al. Thyroid-stimulating antibodies in patients with long-term remission of Graves' hyperthyroidism. Klin Wochenschr 64, 1097–1100 (1986). https://doi.org/10.1007/BF01726868
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01726868